High Quality Nesiritide Acetate (BNP-32) CAS 114471-18-0
 Description High Quality Nesiritide Acetate (BNP-32) CAS 114471-18-0  Description High Quality Nesiritide Acetate (BNP-32) CAS 114471-18-0 Tattoo T-Shirt,New Stylish T-Shirt,Sleeves Tattoo T-Shirts Rongtian Import & Export Co., Ltd. , http://www.ywtattoomachine.comHigh Quality Nesiritide Acetate (BNP-32) CAS 114471-18-0
Cas No.: 114471-18-0
Molecular Formula :Â C143H244N50O42 S4
Molecular Weight: 3464.04
Purity (HPLC): 97.0%min.
Appearance :Â White powder
 Nesiritide of synthetic recombinant human B -type natriuretic peptide (recombined human B-type natriuretic peptide, rhBNP), and ventricular natural natriuretic peptide secretion sodium has the same 32 amino acid sequence . Nesiritide with guanylyl vascular smooth muscle and endothelial cells cyclase receptors, increase intracellular cGMP content , cGMP as a second messenger to make arteriovenous expansion. Studies have shown that nesiritide make endothelin or α- adrenergic receptor agonist treatment of isolated human artery and vein dilation . In the human body, nesiritide dose- dependent reduction in heart failure patients with pulmonary capillary wedge wedge pressure (pulmonary capillarywedge pressure, PCWP) and arterial pressure.
 High Quality Nesiritide Acetate (BNP-32) CAS 114471-18-0
Cas No.: 114471-18-0
Molecular Formula :Â C143H244N50O42 S4
Molecular Weight: 3464.04
Purity (HPLC): 97.0%min.
Appearance :Â White powder
 Nesiritide of synthetic recombinant human B -type natriuretic peptide (recombined human B-type natriuretic peptide, rhBNP), and ventricular natural natriuretic peptide secretion sodium has the same 32 amino acid sequence . Nesiritide with guanylyl vascular smooth muscle and endothelial cells cyclase receptors, increase intracellular cGMP content , cGMP as a second messenger to make arteriovenous expansion. Studies have shown that nesiritide make endothelin or α- adrenergic receptor agonist treatment of isolated human artery and vein dilation . In the human body, nesiritide dose- dependent reduction in heart failure patients with pulmonary capillary wedge wedge pressure (pulmonary capillarywedge pressure, PCWP) and arterial pressure.
Â